Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of aspirin for primary prevention of ASCVDs in type 2 diabetes mellitus patients
TCTR20240328011Completed
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of aspirin in atherosclerotic disease, sponsored by None. Started Jan 2018; status: completed.
02
Drugs
aspirin
03
Conditions
atherosclerotic disease
Beyond the preview
Go deeper on TCTR20240328011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240328011.